0.12% chlorhexidine mouthrinse

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Healthy Subjects

Drug Information

Target Indication

Healthy Subjects

Clinical Trial

Last updated: 2/4/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

GSK

GSK plc

Related Pipeline

Dental Caries

Hepatitis B

Pulmonary Disease, Chronic Obstructive

Acute Coronary Syndrome

Infections, Meningococcal

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts